登录
注册
个人信息
我的订单
我的报告豆
我的优惠券
我的笔记
我的阅读
我的收藏
我的下载
我的上传
我的订阅
在线客服
退出登录
回到首页
AI
搜索
发现报告
发现数据
发现专题
专题报告
专题百科
研选报告
定制报告
VIP
权益
付费社群
发现一下
行业研究
公司研究
宏观策略
财报
招股书
会议纪要
🔗 AI接入
Token
低空经济
十五五
AIGC
大模型
当前位置:首页
/
公司研究
/
报告详情
Overseas growth remained solid; domestic recovery should broaden in 2027E
2026-11-02
Jill W,Cathy WANG
招银国际
欧阳晓辉
你可能感兴趣
Post-results pullback overreacted; solid growth outlook of overseas mining trucks
招银国际
2026-11-02
中国银行业: fundamentals remained solid in 4Q24
BOCI
2025-02-27
China's pharmaceutical distributors continue to be hindered by weak domestic recovery, with profitability recovery failing to offset the slowdown in profit growth. Maintain the \"Hold\" rating on Shanghai Pharmaceutical A/H and Sinopharm Group.
医药生物
汇丰前海证券
2026-04-08
Macro Views:Export Volume Growth Remained High in July
信息技术
Huatai Financial Holdings (Hong Kong) Limited
2024-08-13
Sluggish overseas revenue growth in 3Q26 due to wars
机械设备
招银国际
2026-10-30
Solid core earnings growth in 1Q26; price hikes to bring ST headwinds to revenue growth
招银国际
2026-05-13
China Unicom Results in line mobile ARPU achieves solid growth
华泰金融
2022-03-13
China PMI Analysis:April PMI shows solid growth, but also a surge in inflationary pressure
CSFB
2010-05-04
Expect profit growth in FY26-27 following 2H25 new-car GPM recovery, new HIMA stores
招银国际
2026-04-01
Domestic biotech leader; poised for continued growth
信达国际
2016-09-19